%0 Journal Article %A Yosuke Fujii %A Hiroki Daijo %A Kiichi Hirota %T Estimation of the number of general anesthesia cases based on a series of nationwide surveys on Twitter during COVID-19 in Japan: A statistical analysis %D 2020 %R 10.1101/2020.05.08.20094979 %J medRxiv %P 2020.05.08.20094979 %X Purpose The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread to more than 200 other countries. In light of this situation, the Japanese Government declared a state of emergency in seven regions of Japan on April 7, 2020, under the provisions of the law. The medical care delivery system has been under pressure. Although various surgical societies have published guidelines on which to base their surgical decisions, it is not clear how general anesthesia has been performed and will be performed in Japan.Methods One of the services provided by Twitter is a voting function—Twitter Polls—through which anonymous surveys can be conducted. We used quadratic programming to analyze the results of a series of 17 surveys on Twitter, over the course of 22 weeks. The analysis focused on solving the mathematical optimizing problem on the status of operating restrictions. Public data provided by the Japanese Government were used to estimate the current changes in the number of general anesthesia performed in Japan.Results The minimum number of general anesthesia per week was estimated at 66.1%, compared to 2015, on April 27, 2020. The time series trend was compatible with the results reported by the Japanese Society of Anesthesiologists.Conclusion The number of general anesthesia was reduced by up to two-thirds during the COVID-19 pandemic in Japan, and was quantitatively estimated using the Twitter quick questionnaire.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a research grant from the Kansai Medical University (KMU) research consortium to K.H., the branding program as a world-leading research university on intractable immune and allergic diseases from MEXT Japan.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is exempted from institutional review board approval because this study does contain no human participants, or research material derived from human participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request. https://github.com/yfujii08/covid19generalanesthesia %U https://www.medrxiv.org/content/medrxiv/early/2020/09/28/2020.05.08.20094979.full.pdf